Concepts (181)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Administration, Intravenous
- Administration, Oral
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Algorithms
- alpha-Mannosidase
- Angiogenesis Inhibitors
- Animals
- Antibiotics, Antineoplastic
- Antibodies, Monoclonal, Humanized
- Antigens, CD
- Antineoplastic Agents
- Antineoplastic Agents, Immunological
- Antineoplastic Combined Chemotherapy Protocols
- Asbestos
- B7 Antigens
- B7-H1 Antigen
- Betacoronavirus
- Bevacizumab
- Biomarkers, Tumor
- Bridged-Ring Compounds
- Cancer Vaccines
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Cardiotoxicity
- Cardiovascular Diseases
- Cause of Death
- Cell Count
- Cell Line, Tumor
- Cell Proliferation
- Cell-Free Nucleic Acids
- Circulating Tumor DNA
- Cisplatin
- Clinical Decision-Making
- Cohort Studies
- Comorbidity
- Compassionate Use Trials
- Congresses as Topic
- Continuity of Patient Care
- Coronavirus
- Coronavirus Infections
- C-Reactive Protein
- Cross-Sectional Studies
- CTLA-4 Antigen
- Databases, Factual
- Decision Making
- Disease Progression
- Disease-Free Survival
- DNA, Neoplasm
- Double-Blind Method
- Doxorubicin
- Drug Administration Schedule
- Drug Delivery Systems
- Drug Design
- Drug Evaluation
- Drug Resistance, Neoplasm
- Drug Therapy
- Drugs, Investigational
- Early Detection of Cancer
- ErbB Receptors
- Erlotinib Hydrochloride
- Etoposide
- Exosomes
- Female
- Fibrin Fibrinogen Degradation Products
- Fluorodeoxyglucose F18
- Folic Acid Antagonists
- Follow-Up Studies
- Gene Rearrangement
- Glycolysis
- Hematologic Neoplasms
- Hepatitis A Virus Cellular Receptor 2
- High-Throughput Nucleotide Sequencing
- Hospitalization
- Humans
- Image Processing, Computer-Assisted
- Immune System
- Immunocompromised Host
- Immunomodulation
- Immunophenotyping
- Immunotherapy
- Immunotherapy, Active
- Inhibitory Concentration 50
- Intensive Care Units
- Italy
- Kaplan-Meier Estimate
- Killer Cells, Natural
- Liquid Biopsy
- Longitudinal Studies
| - Lung Neoplasms
- Lymph Nodes
- Lymphatic Metastasis
- Lymphocyte Activation
- Male
- Mass Screening
- Medical Oncology
- Melanoma
- Mesothelioma
- MicroRNAs
- Microtubules
- Middle Aged
- Models, Biological
- Molecular Structure
- Molecular Targeted Therapy
- Multimodal Imaging
- Mutation
- Myocarditis
- Neoplasm Metastasis
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Neoplasms
- Neoplastic Cells, Circulating
- Noninvasive Ventilation
- Occupational Exposure
- Occupational Health
- Oligopeptides
- Oncogene Addiction
- Oncologists
- Oncology Service, Hospital
- Osteopontin
- Pandemics
- Patient Selection
- Pemetrexed
- Personnel Staffing and Scheduling
- Pilot Projects
- Platinum
- Platinum Compounds
- Pleural Neoplasms
- Pneumonia, Viral
- Positron Emission Tomography Computed Tomography
- Practice Patterns, Physicians'
- Predictive Value of Tests
- Prognosis
- Programmed Cell Death 1 Receptor
- Proportional Hazards Models
- Proprotein Convertase 9
- Prospective Studies
- Protein Kinase Inhibitors
- Protein-Tyrosine Kinases
- Proto-Oncogene Proteins
- Proto-Oncogene Proteins c-met
- Radiopharmaceuticals
- Receptor Protein-Tyrosine Kinases
- Receptors, Fibroblast Growth Factor
- Receptors, KIR
- Recombinant Fusion Proteins
- Registries
- Reproducibility of Results
- Retreatment
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Salvage Therapy
- Sensitivity and Specificity
- Serine
- Severity of Illness Index
- Sex Factors
- Small Cell Lung Carcinoma
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
- Surveys and Questionnaires
- Survival Analysis
- Survival Rate
- Taxoids
- Telemedicine
- Teprotide
- Thoracic Neoplasms
- Time Factors
- T-Lymphocyte Subsets
- Tomography, X-Ray Computed
- Treatment Outcome
- Triage
- Troponin
- Troponin I
- Troponin T
- Tubulin Modulators
- Tumor Burden
- Tumor Necrosis Factor-alpha
- Vaccination
- Withholding Treatment
|
Grossi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(181)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(201)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_